Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-24-000508
Filing Date
2024-12-11
Accepted
2024-12-11 17:00:27
Documents
1
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 12-09-2024 form_4.html 4  
1 FORM 4 FOR 12-09-2024 form_4.xml 4 5835
  Complete submission text file 0001161697-24-000508.txt   7576
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10975 N. TORREY PINES RD., SUITE 150 LA JOLLA CA 92037
Business Address
Thompson Tamar (Reporting) CIK: 0001839248 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 241542261